Skip to main content

Advertisement

ADVERTISEMENT

Department

Conference Insider
04/13/2023
Maria Asimopoulos
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE,...
04/13/2023
First Report Managed Care
Conference Insider
04/13/2023
Maria Asimopoulos
Emma Searle, MD, PhD, reviews early data from MajesTEC-2, a trial designed to evaluate the recently approved monoclonal antibody teclistamab in combination with daratumumab and lenalidomide in patients with relapsed/refractory multiple...
Emma Searle, MD, PhD, reviews early data from MajesTEC-2, a trial designed to evaluate the recently approved monoclonal antibody teclistamab in combination with daratumumab and lenalidomide in patients with relapsed/refractory multiple...
Emma Searle, MD, PhD, reviews...
04/13/2023
First Report Managed Care

Advertisement

News Connection
12/22/2022
News Connection features the latest industry updates from the November/December 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the November/December 2022 issue of First Report Managed Care.
News Connection features the...
12/22/2022
First Report Managed Care
News Connection
09/23/2022
News Connection features the latest industry updates from the September/October 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the September/October 2022 issue of First Report Managed Care.
News Connection features the...
09/23/2022
First Report Managed Care
News Connection
08/02/2022
News Connection features the latest industry updates from the July/August 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the July/August 2022 issue of First Report Managed Care.
News Connection features the...
08/02/2022
First Report Managed Care

Advertisement

Interview
04/18/2022
Samantha Matthews
In this interview, Robert Gibbons, PhD, discusses his work to advance mental health research and utilize the computerized adaptive test suicide scale for the United States veteran population.
In this interview, Robert Gibbons, PhD, discusses his work to advance mental health research and utilize the computerized adaptive test suicide scale for the United States veteran population.
In this interview, Robert...
04/18/2022
First Report Managed Care
Conference Insider
03/15/2022
Edan Stanley
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent...
03/15/2022
First Report Managed Care
Conference Insider
03/15/2022
Samantha Matthews
Compared to healthy adults, patients with severe asthma or atopic dermatitis on biologic therapies have lower antibody levels after SARS-CoV-2 mRNA vaccination, according to study findings presented at the 2022 American Academy of Allergy,...
Compared to healthy adults, patients with severe asthma or atopic dermatitis on biologic therapies have lower antibody levels after SARS-CoV-2 mRNA vaccination, according to study findings presented at the 2022 American Academy of Allergy,...
Compared to healthy adults,...
03/15/2022
First Report Managed Care

Advertisement

Conference Insider
03/15/2022
Maria Asimopoulos
“The results from this study are encouraging, indicating that an epinephrine treatment alternative, which can be administered sublingually for cases of life-threatening allergic reactions, has the potential to meet the therapeutic window...
“The results from this study are encouraging, indicating that an epinephrine treatment alternative, which can be administered sublingually for cases of life-threatening allergic reactions, has the potential to meet the therapeutic window...
“The results from this study are...
03/15/2022
First Report Managed Care
News Connection
02/07/2022
News Connection features the latest industry updates from the January/February 2022 issue of First Report Managed Care.
News Connection features the latest industry updates from the January/February 2022 issue of First Report Managed Care.
News Connection features the...
02/07/2022
First Report Managed Care

Advertisement